Guilford, Pfizer deal

By WIR Staff | May 12, 2003 | 7:00 AM GMT

PFE received exclusive worldwide rights to a class of n-acetylated-alpha-linked-acidic-dipeptidase ( NAALADase) inhibitors from GLFD to treat